Abstract
Genetic analysis of complex diseases is undergoing a paradigm shift as the DNA technology and computational resources for analysis become more precise. In this review we compare the old paradigm for genetic disease analysis with the new, more powerful and efficient methods, which rely on the application of genetically linked markers. To illustrate the utility of the new approach, we apply it in the study of ankylosing spondylitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have